comparemela.com

Latest Breaking News On - Kevinr sayer - Page 10 : comparemela.com

DexCom, Inc (NASDAQ:DXCM) CEO Kevin R Sayer Sells 37,325 Shares

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) CEO Kevin R. Sayer sold 37,325 shares of the company’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $123.63, for a total value of $4,614,489.75. Following the transaction, the chief executive officer now directly owns 362,841 shares in the […]

Wealthfront Advisers LLC Buys 2,673 Shares of DexCom, Inc (NASDAQ:DXCM)

Wealthfront Advisers LLC Buys 2,673 Shares of DexCom, Inc (NASDAQ:DXCM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

DexCom, Inc (NASDAQ:DXCM) Shares Sold by Mitsubishi UFJ Asset Management UK Ltd

Mitsubishi UFJ Asset Management UK Ltd. reduced its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 90.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the medical device company’s stock after selling 19,000 shares […]

Q1 2025 EPS Estimates for DexCom, Inc Increased by Zacks Research (NASDAQ:DXCM)

DexCom, Inc. (NASDAQ:DXCM – Get Rating) – Equities researchers at Zacks Research boosted their Q1 2025 earnings estimates for shares of DexCom in a report issued on Wednesday, June 21st. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical device company will earn $0.36 per share for the quarter, up from their prior forecast […]

Zacks Research Research Analysts Lift Earnings Estimates for DexCom, Inc (NASDAQ:DXCM)

DexCom, Inc. (NASDAQ:DXCM – Get Rating) – Research analysts at Zacks Research boosted their Q1 2025 earnings estimates for DexCom in a research report issued to clients and investors on Wednesday, June 21st. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical device company will post earnings per share of $0.36 for the quarter, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.